Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

Ann Intern Med. 2003 Jan 7;138(1):1-9.

PMID:
12513038
3.

The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

Wells G, Herrington DM.

Drugs Aging. 1999 Dec;15(6):419-22. Review.

PMID:
10641952
4.

Hormone replacement therapy for prevention of coronary heart disease: current evidence.

Khurana PS, Khurana C, Hsia J.

Curr Atheroscler Rep. 2001 Sep;3(5):399-403. Review.

PMID:
11487451
5.

Postmenopausal hormone use for cardioprotection: what we know and what we must learn.

Wenger NK.

Curr Opin Cardiol. 1999 Jul;14(4):292-7. Review.

PMID:
10448608
6.

[Hormone replacement therapy of menopause, heart and blood vessels].

Kuttenn F, Gerson M.

Arch Mal Coeur Vaiss. 2001 Jul;94(7):685-9. Review. French.

PMID:
11494629
7.

[Menopause and hormone replacement therapy (HRT) in women with diabetes].

Cyganek K.

Przegl Lek. 1999;56(5):362-71. Review. Polish.

PMID:
10554574
8.
10.
11.

Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.

Hodis HN, Mack WJ, Lobo R.

Curr Atheroscler Rep. 2002 Jan;4(1):52-8. Review.

PMID:
11772423
12.

The new conundrum: do estrogens have any cardiovascular benefits?

Clarkson TB.

Int J Fertil Womens Med. 2002 Mar-Apr;47(2):61-8. Review.

PMID:
11991432
13.

Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.

Barbour MM.

Pharmacotherapy. 2000 Sep;20(9):1021-7. Review. No abstract available.

PMID:
10999492
14.

Postmenopausal hormone therapy. Is it useful for coronary prevention?

Wenger NK.

Cardiol Clin. 1998 Feb;16(1):17-25. Review.

PMID:
9507777
15.

Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.

Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE.

Diabetes Obes Metab. 2006 Sep;8(5):538-54. Review.

PMID:
16918589
16.

Effect of postmenopausal hormone therapy on cardiovascular risk.

Rossouw JE.

J Hypertens Suppl. 2002 May;20(2):S62-5. Review.

PMID:
12183856
17.

The role of hormone replacement therapy in the prevention of postmenopausal heart disease.

Mosca L.

Arch Intern Med. 2000 Aug 14-28;160(15):2263-72. Review.

PMID:
10927722
18.

[Hormonal supplement therapy in women: effects on the cardiovascular system].

Maas AH, van Gilst WH, Verheugt FW.

Ned Tijdschr Geneeskd. 2001 Jan 13;145(2):65-9. Review. Dutch.

PMID:
11225258
19.

Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.

Kahn HS, Curtis KM, Marchbanks PA.

Diabetes Care. 2003 Jan;26(1):216-25. Review.

PMID:
12502684
20.

Hormone replacement therapy and coronary artery disease.

Morris D.

Curr Opin Obstet Gynecol. 1996 Jun;8(3):184-7. Review.

PMID:
8818528

Supplemental Content

Support Center